Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Post by Aubreyon May 05, 2015 10:18pm
225 Views
Post# 23697839

expectations

expectations   I was wondering why the roll out of the TLC-2000 was so slow. But consider that Theralase only hired the engineering staff to complete the design on May 15/14 (less than a year ago) and now it is at the cusp of being approved in lee than one year!. The engineers also developed the TLC-3000 which launched on Sept 9/14, it's first duties were to activate the 96 well plates to speed up the cancer research. In the world of engineering thats fast work.
  I was expecting robust sales data in Jan..and then charging into the USA. then I found myself disapointed with the current time lines.  Then I realized Theralase just hired a marketing manager in Feb/15. 
  Then I reviewed the historic news releases, and I see all of what Roger was vsioning over the past several years is actually happening. Roger wasn't crying wolf back then, he was sharing his vision for the future. As I see this, things are progressing very well.
  My problem has been my unrealistic expectations about the time lines...and impatience.
  Sound familiar?  
 
   
Bullboard Posts